FDA conducts inspection at Savor Patisserie, LLC in Garland on Feb. 19

Sean R. Keveney J.D., Chief Counsel of FDA
Sean R. Keveney J.D., Chief Counsel of FDA
0Comments

The Food and Drug Administration (FDA) performed an inspection at Savor Patisserie, LLC in Garland on Feb. 19, according to data posted on the FDA’s website.

The review encompassed these focus areas:

  • Food Composition, Standards, Labeling and Econ
  • Foodborne Biological Hazards

The inspection report concluded there was no need for Savor Patisserie, LLC to implement corrective actions related to its management operations.

The FDA regularly inspects facilities across the United States to verify that workplaces and their products comply with laws and regulations intended to protect public health. Inspection results are made available to the public.

According to its website, the FDA is a federal agency responsible for overseeing the production and distribution of human and animal drugs, biological products, medical supplies, and tobacco items for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Dr. Mehmet Oz CMS Administrator

Richardson sees $6,953,256 in Medicaid payments for alcohol and drug abuse treatment in 2024

In 2024, Medicaid providers in Richardson reported $6,953,256 in billings for Alcohol and Drug Abuse Treatment services, reflecting a 7.8% rise from the prior year.

Dr. Mehmet Oz CMS Administrator

Carrollton Medicaid claims for alcohol and drug treatment hit $662,943 in 2024

Carrollton Medicaid providers reported $662,943 in claims for Alcohol and Drug Abuse Treatment in 2024, representing a 16.1% increase over the prior year.

Kyle Diamantas, J.D., Deputy Commissioner for Human Foods of FDA

How many companies in cities across Dallas County received FDA citations in 2025?

There were 79 companies in cities associated with Dallas County that received FDA citations as a result of 80 inspections conducted in the county in 2025, according to reports from the U.S. Food and Drug Administration (FDA).